Testosterone level and risk of type 2 diabetes in men: a systematic review and meta-analysis

META-ANALYSIS
 | 
2018
Yao Q
Wang B
An X
Zhang JA
Ding L
Summary

BACKGROUND: Type 2 diabetes is a risk factor for testosterone deficiency and impaired sex steroid status. Some studies also investigated the association of testosterone level with diabetes risk in men, but reported controversial findings. To clarify this issue, we conducted a systematic review and meta-analysis.

METHODS: Pubmed, Embase, and Web of Science were searched for eligible cohort or nested case-control studies published up to August 15, 2017. Meta-analysis was used to calculate the pooled relative risk (RR) of type 2 diabetes associated with higher testosterone level.

RESULTS: Thirteen cohort or nested case-control studies with 16,709 participants were included. Meta-analysis showed that higher total testosterone level could significantly decrease the risk of type 2 diabetes in men (RR = 0.65; 95%CI 0.50-0.84; P = 0.001), and higher free testosterone level could also decrease the risk of type 2 diabetes in men (RR = 0.94; 95%CI 0.90-0.99; P = 0.014).

After excluding two studies which did not calculate RRs by quartiles of testosterone levels, both higher total testosterone and free testosterone levels could decrease the risk of type 2 diabetes in men, and the pooled RRs were 0.62 (95%CI 0.51-0.76; P < 0.001) and 0.77 (95%CI 0.61-0.98; P= 0.03), respectively.

CONCLUSION: This meta-analysis suggests that higher testosterone level can significantly decrease the risk of type 2 diabetes in men. Therefore, combined with previous researches, the findings above suggest a reverse-causality scenario in the relation between testosterone deficiency and risk of type 2 diabetes in men.

Keywords
type 2 diabetes
glycemic control
blood blucose
hba1c
Comments

It should be noted that there appears to be a bidirectional link between lower testosterone levels and T2DM: low T increases risk of T2DM, and T2DM increases risk of low T levels (reverse-causality).

  • PP-NEB-ALL-0347-1

Copyright © 2019,
Bayer AG

This website is intended to provide information to an international audience outside the USA and UK.

Page last modified Tue, 20/08/2019

Bayer logo